Hi all,
It's amazing to see how many people panic here without understanding the broader pic or even bother to read the ann.
"Board promised high grade of 75g/t!"
"BOD has pumped this to 4.3c!"
It's obvious when downrampers/trolls are just inserting fears and nonsense into this thread. There's a reason why HC has an ignore button and it'll do great wonders for real investors who care about ADV.
Everyone need to take a chill pill and actually read the report in depth. Today's announcement only contains results of 4 holes out of 10 holes which have been drilled at Kasagiminnis, 1 of the 19 gold prospects ADV has. Now, the results might not have been outstanding but it's definitely good grades at this depth which is less than 250m. ADV plans to drill deeper and is still on track to grow the resource to the 0.5-1.2Moz exploration target.
"Drilling has so far only tested a small portion of the first 250m below surface to provide better understanding of controls on mineralisation before targeting deeper drilling.
Now, for those saying what we have now it's not high grade, just look at other mines that's mentioned:
It's also important to know that gold within this region is much deeper and that's why ADV has stressed the importance of drilling deeper beyond 300m and explains this in details in this page below with long section diagram.
Finally, don't forget just how extensive ADV's holding is within this prominent gold region with many other mines nearby and many more drilling planned well into 2021.
If you reckon after reading the above, ADV at 3.3c and MC of $70M is overhyped/overvalued, I suggest you think again.
But that's just me.
GLTAH and DYOR
- Forums
- ASX - By Stock
- ADV
- Ann: Initial Kasagiminnis Assays Show Strong Gold Mineralisation
Ann: Initial Kasagiminnis Assays Show Strong Gold Mineralisation, page-106
-
- There are more pages in this discussion • 113 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADV (ASX) to my watchlist
(20min delay)
|
|||||
Last
14.0¢ |
Change
0.005(3.70%) |
Mkt cap ! $8.752M |
Open | High | Low | Value | Volume |
13.5¢ | 14.0¢ | 13.5¢ | $824 | 5.946K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 31992 | 13.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.5¢ | 4069 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 31992 | 0.135 |
2 | 145384 | 0.130 |
1 | 120000 | 0.125 |
2 | 86903 | 0.115 |
2 | 68181 | 0.110 |
Price($) | Vol. | No. |
---|---|---|
0.145 | 4069 | 1 |
0.150 | 50000 | 1 |
0.155 | 172358 | 2 |
0.185 | 45000 | 1 |
0.190 | 34262 | 3 |
Last trade - 13.27pm 15/07/2024 (20 minute delay) ? |
Featured News
ADV (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online